MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1007/s11060-016-2341-4

Медицинская библиотека · Journal of neuro-oncology · 2016

Survival in pediatric medulloblastoma: a population-based observational study to improve prognostication.

Weil Alexander G, Wang Anthony C, Westwick Harrison J, Ibrahim George M, Ariani Rojine T, Crevier Louis, Perreault Sebastien, Davidson Tom, Tseng Chi-Hong, Fallah Aria

СтатьяНаблюдательное исследованиеПеревод пока не подготовлен

Аннотация

Medulloblastoma is the most common form of brain malignancy of childhood. The mainstay of epidemiological data regarding childhood medulloblastoma is derived from case series, hence population-based studies are warranted to improve the accuracy of survival estimates. To utilize a big-data approach to update survival estimates in a contemporary cohort of children with medulloblastoma. We performed a population-based retrospective observational cohort study utilizing the Surveillance, Epidemiology, and End Results Program database that captures all children, less than 20 years of age, between 1973 and 2012 in 18 geographical regions representing 28% of the US population. We included all participants with a presumed or histologically diagnosis of medulloblastoma. The main outcome of interest is survivors at 1, 5 and 10 years following diagnosis. A cohort of 1735 children with a median (interquartile range) age at diagnosis of 7 (4-11) years, with a diagnosis of medulloblastoma were identified. The incidence and prevalence of pediatric medulloblastoma has remained stable over the past 4 decades. There is a critical time point at 1990 when the overall survival has drastically improved. In the contemporary cohort (1990 onwards), the percentage of participants alive was 86, 70 and 63% at 1, 5 and 10 years, respectively. Multivariate Cox-Regression model demonstrated Radiation (HR 0.37; 95% CI 0.30-0.46, p < 0.001) and Surgery (HR 0.42; 95% CI 0.30-0.58, p < 0.001) independently predict survival. The probability of mortality from a neurological cause is <5% in patients who are alive 8 years following diagnosis. The SEER cohort analysis demonstrates significant improvements in pediatric medulloblastoma survival. In contrast to previous reports, the majority of patients survive in the modern era, and those alive 8 years following initial diagnosis are likely a long-term survivor. The importance of minimizing treatment-related toxicity is increasingly apparent given the likelihood of long-term survival.

Для цитирования: Weil Alexander G, Wang Anthony C, Westwick Harrison J, Ibrahim George M, Ariani Rojine T, Crevier Louis, Perreault Sebastien, Davidson Tom, Tseng Chi-Hong, Fallah Aria. Survival in pediatric medulloblastoma: a population-based observational study to improve prognostication.. Journal of neuro-oncology. 2016. DOI: 10.1007/s11060-016-2341-4.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.